Biogen to Present at the Bernstein 33rd Annual Strategic Decisions Conference
May 17 2017 - 4:01PM
Business Wire
Biogen Inc. (NASDAQ: BIIB) announced today that it will present
at the Bernstein 33rd Annual Strategic Decisions Conference. The
webcast will be live on Wednesday, May 31, 2017 at 3:00 p.m.
EDT. To access the live webcast, please visit Biogen’s
Investors section at www.biogen.com/investors. An archived version
of the webcast will be available following the presentation.
About Biogen
Through cutting-edge science and medicine, Biogen discovers,
develops and delivers innovative therapies worldwide for people
living with serious neurological and neurodegenerative diseases.
Founded in 1978, Biogen is a pioneer in biotechnology and today the
Company has the leading portfolio of medicines to treat multiple
sclerosis, has introduced the first and only approved treatment for
spinal muscular atrophy, and is at the forefront of neurology
research for conditions including Alzheimer’s disease, Parkinson’s
disease and amyotrophic lateral sclerosis. Biogen also manufactures
and commercializes biosimilars of advanced biologics. For more
information, please visit www.biogen.com. Follow us on social media
– Twitter, LinkedIn, Facebook, YouTube.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170517006161/en/
BiogenKaren Jewell, 781-464-2442Investor Relations
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Sep 2023 to Sep 2024